These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32919304)

  • 1. Proteomics reveals protein phosphatase 1γ as a biomarker associated with Hippo signal pathway in glioma.
    Xue J; Sang W; Su LP; Gao HX; Cui WL; Abulajiang G; Wang Q; Zhang J; Zhang W
    Pathol Res Pract; 2020 Nov; 216(11):153187. PubMed ID: 32919304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein phosphatase 1γ regulates the proliferation of human glioma via the NF-κB pathway.
    Bao Z; Duan C; Gong C; Wang L; Shen C; Wang C; Cui G
    Oncol Rep; 2016 May; 35(5):2916-26. PubMed ID: 26936744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
    Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
    Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidence.
    Guichet PO; Masliantsev K; Tachon G; Petropoulos C; Godet J; Larrieu D; Milin S; Wager M; Karayan-Tapon L
    J Pathol; 2018 Oct; 246(2):205-216. PubMed ID: 30009411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of YAP1 and pSTAT3-S727 and their prognostic value in glioma.
    Sang W; Xue J; Su LP; Gulinar A; Wang Q; Zhai YY; Hu YR; Gao HX; Li X; Li QX; Zhang W
    J Clin Pathol; 2021 Aug; 74(8):513-521. PubMed ID: 33020176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Expression and Prognostic Value of ILK and YAP1 in Glioma.
    Wang Q; Sang W; Xue J; Zhai Y; Hu Y; Su L; Zhang W
    Appl Immunohistochem Mol Morphol; 2022 Mar; 30(3):e21-e29. PubMed ID: 35262527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autophagy-associated biomarkers ULK2, UVRAG, and miRNAs miR-21, miR-126, and miR-374: Prognostic significance in glioma patients.
    Amin W; Enam SA; Sufiyan S; Ghias K; Bajwa MH; Ilyas S; Laghari AA; Naeem S; Abidi SH; Mughal N
    PLoS One; 2024; 19(9):e0311308. PubMed ID: 39348350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors.
    Aguennouz M; Polito F; Visalli M; Vita G; Raffa G; Oteri R; Ghazi B; Scalia G; Angileri FF; Barresi V; Caffo M; Cardali S; Conti A; Macaione V; Bartolotta M; Giorgio RD; Germanò A
    Cancer Treat Res Commun; 2020; 24():100203. PubMed ID: 32777750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serine Incorporator 2 (SERINC2) Expression Predicts an Unfavorable Prognosis of Low-Grade Glioma (LGG): Evidence from Bioinformatics Analysis.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    J Mol Neurosci; 2020 Oct; 70(10):1521-1532. PubMed ID: 32642801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
    Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX
    Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
    Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary morphogenesis protein 2 is a novel prognostic biomarker and plays oncogenic roles in glioma.
    Tan J; Liu M; Zhang JY; Yao YL; Wang YX; Lin Y; Song K; Tan J; Wu JR; Cui YH; Wang Y; Bian XW
    J Pathol; 2018 Jun; 245(2):160-171. PubMed ID: 29473166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between small heat shock protein B11 and the prognostic value of MGMT promoter methylation in patients with high-grade glioma.
    Cheng W; Li M; Jiang Y; Zhang C; Cai J; Wang K; Wu A
    J Neurosurg; 2016 Jul; 125(1):7-16. PubMed ID: 26544773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylated mTOR and YAP serve as prognostic markers and therapeutic targets in gliomas.
    Liu M; Lin Y; Zhang XC; Tan YH; Yao YL; Tan J; Zhang X; Cui YH; Liu X; Wang Y; Bian XW
    Lab Invest; 2017 Nov; 97(11):1354-1363. PubMed ID: 28759011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The correlation of bone morphogenetic protein 2 with poor prognosis in glioma patients.
    Yang X; Li D; Cheng S; Fan K; Sheng L; Zhang J; Feng B; Xu Z
    Tumour Biol; 2014 Nov; 35(11):11091-5. PubMed ID: 25099618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLEKHG5 is a novel prognostic biomarker in glioma patients.
    Qian M; Chen Z; Wang S; Guo X; Zhang Z; Qiu W; Gao X; Xu J; Zhao R; Xue H; Li G
    Int J Clin Oncol; 2019 Nov; 24(11):1350-1358. PubMed ID: 31309383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTC1 as an invasion and prognosis marker in glioma.
    Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
    J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined elevation of AURKB and UBE2C predicts severe outcomes and therapy resistance in glioma.
    Alafate W; Zuo J; Deng Z; Guo X; Wu W; Zhang W; Xie W; Wang M; Wang J
    Pathol Res Pract; 2019 Oct; 215(10):152557. PubMed ID: 31353228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic value of the WEE1 kinase in gliomas.
    Music D; Dahlrot RH; Hermansen SK; Hjelmborg J; de Stricker K; Hansen S; Kristensen BW
    J Neurooncol; 2016 Apr; 127(2):381-9. PubMed ID: 26738845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF2 as a potential prognostic biomarker for proneural glioma patients.
    Sooman L; Freyhult E; Jaiswal A; Navani S; Edqvist PH; Pontén F; Tchougounova E; Smits A; Elsir T; Gullbo J; Lennartsson J; Bergqvist M; Ekman S
    Acta Oncol; 2015 Mar; 54(3):385-94. PubMed ID: 25263081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.